www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-03-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-03-20T16:33:27.577Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the PACE trial of therapies on reducing the effects of (a) myalgic encephalomyelitis and (b) chronic fatigue syndrome.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "231512"}
, {"_about" : "http://data.parliament.uk/resources/1087043", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1087043/answer", "answerText" : {"_value" : "We have no current plans to allocate funding to the Institute of Health Equity and Health Foundation review of Fair Society, Healthy Lives. We look forward to seeing the review\u2019s conclusions in February 2020. Reducing health inequalities remains a priority for the Department and is central to the NHS Long Term Plan and the Secretary of State\u2019s prevention priority.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-03-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-03-20T16:24:12.6Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health: Disadvantaged"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to allocate funding for the ten-year review of progress on reducing health inequalities since the publication of the report entitled Fair Society, Healthy Lives, published by Michael Marmot.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "231513"}
, {"_about" : "http://data.parliament.uk/resources/1064303", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1064303/answer", "answerText" : {"_value" : "
Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.<\/p>
<\/p>
My Rt. hon. Friend Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-26T12:17:17.53Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Health Professions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the Health Education England phase two cancer workforce plan co-ordinates with the workforce implementation plan in the NHS Long Term Plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "223778"}
, {"_about" : "http://data.parliament.uk/resources/1064309", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1064309/answer", "answerText" : {"_value" : "
A search of the Department\u2019s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only.<\/p>
<\/p>
We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify \u2018urgent goods\u2019, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.<\/p>
<\/p>
From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department\u2019s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-02-28", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "224533"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-28T11:47:48.99Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radioisotopes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what representations he has received on alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "223789"}
, {"_about" : "http://data.parliament.uk/resources/1064781", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1064781/answer", "answerText" : {"_value" : "
A search of the Department\u2019s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only.<\/p>
<\/p>
We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify \u2018urgent goods\u2019, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.<\/p>
<\/p>
From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department\u2019s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-02-28", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "223789"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-28T11:47:49.033Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radioisotopes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of a shortage of radioisotopes on the number of breast cancer diagnostic and treatment procedures.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "224533"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Thangam+Debbonaire&_page=1&answeringDeptId=17&max-ddpModified.=2019-07-04T17%3A25%3A42.004Z", "page" : 0, "startIndex" : 1, "totalResults" : 84, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}